Korea Quantum Computing (Chairman Kwon Ji-hoon, hereinafter referred to as KQC), a company that operates quantum computing, quantum security, and AI infrastructure, announced on the 15th that it has signed a memorandum of understanding (MOU) with the Korean Society for Bioinformatics (Chairman Ryu Seong-ho, hereinafter referred to as KSBI) for cooperation in quantum computer-based bioinformatics research.
This agreement was signed at the Korean Society for Bioinformatics' regular academic conference 'BIOINFO 2025' held at the Suwon Convention Center from October 14th to 17th.
KSBI is Korea's leading academic organization in the fields of bioinformatics and systems biology, actively promoting academic advancement, professional development, and international exchange. KQC is a private enterprise leading the development of related infrastructure and technologies, aiming to build a quantum computing industry ecosystem.
This agreement marks the first instance of quantum computing being introduced to bioinformatics at the domestic academic level, raising expectations for future technological cooperation and expanded research and development.
Both organizations aim to leverage the high-performance computing capabilities of quantum computers to efficiently solve complex computational problems in bioinformatics, including new drug development, genome analysis, and protein structure prediction. In particular, by applying quantum algorithms to KSBI's key areas of "AI bio" and "digital bio," they anticipate accelerating large-scale molecular simulations and drug-protein interaction analysis, which have historically been limited by classical computing.
The main contents of the agreement include ▲development of a new drug design algorithm based on quantum computing ▲research on quantum-AI fusion technology for genome data analysis ▲optimization of leading material search in the field of chemoinformatics ▲molecular network analysis based on systems biology ▲operation of a quantum computing education program for bioinformatics researchers.
KSBI President Ryu Seong-ho said, “Quantum computing is a key technology that can shift the paradigm of bioinformatics research,” and added, “I hope that through this collaboration, our society will secure technological competitiveness in the fields of AI bio and digital bio, and become an opportunity to leap forward as a strategic field for national research and development.”
KQC Chairman Kwon Ji-hoon said, “With KQC’s quantum computer access infrastructure and experience in developing algorithms in the bio and pharmaceutical fields, we will support researchers affiliated with KSBI to apply quantum computing to practical research,” adding, “This agreement is an important step forward in expanding quantum technology into the life sciences.”
- See more related articles
You must be logged in to post a comment.